about
Mangiferin and Cancer: Mechanisms of Action.Deconstructing innate immune signaling in myelodysplastic syndromesRecent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4The Alpha-Melanocyte-Stimulating Hormone Suppresses TLR2-Mediated Functional Responses through IRAK-M in Normal Human KeratinocytesIncreased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesityA Standardized Chemically Modified Curcuma longa Extract Modulates IRAK-MAPK Signaling in Inflammation and Potentiates Cytotoxicity.Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma.Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.Cytological Assessments and Transcriptome Profiling Demonstrate that Evodiamine Inhibits Growth and Induces Apoptosis in a Renal Carcinoma Cell Line.Zinc Signals and Immunity.Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis.Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
P2860
Q26745565-73EFF4D8-5D1A-43B7-B06C-FD21B2569707Q26991974-9109DED5-670A-426F-B0C2-37F9590FCCA2Q28078574-25AAE972-1E73-4E63-B434-858FB3CE59ACQ35756125-A18FD4E7-598D-4CC9-BB9C-9E091440A815Q35996863-A61F7933-61EA-4C8B-AF53-B8C283B99EC0Q37122453-AA245032-DCA4-45EB-98E0-BEC8EF0A6BFAQ37251454-1F28E8FD-6554-4D0E-9E30-8B0863E3E679Q37702644-FF580C71-F4F4-4274-9A9B-4DB27DED0CAFQ37702727-E10D6DA3-0945-4742-9B75-8EA263957861Q38295578-EEE5E1E6-4E7F-489B-969A-D9CE8DA3D0DAQ38856948-2FE03FEC-7B27-486E-A8D1-E91DCCABF56FQ39323428-5A81D8F0-19B1-443B-83A1-53F85E24D48CQ42009949-2E263644-DE3F-4FFD-83C2-8CD3AB21E836Q47165288-D505B29F-B559-494E-A998-1BAB549656AFQ47935082-7679463A-9B82-4E63-AFA9-EA73D86C43D3Q50350070-7D9A87E6-8166-4D4F-86EF-4875E4061919Q57116991-051B470B-40FC-4613-AD58-95B30BBAC7B5
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
IRAK signalling in cancer
@ast
IRAK signalling in cancer
@en
IRAK signalling in cancer
@nl
type
label
IRAK signalling in cancer
@ast
IRAK signalling in cancer
@en
IRAK signalling in cancer
@nl
prefLabel
IRAK signalling in cancer
@ast
IRAK signalling in cancer
@en
IRAK signalling in cancer
@nl
P2860
P921
P3181
P356
P1476
IRAK signalling in cancer
@en
P2093
D T Starczynowski
G W Rhyasen
P2860
P2888
P3181
P356
10.1038/BJC.2014.513
P407
P5008
P577
2015-01-20T00:00:00Z
P5875
P6179
1049868952